A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...

Unity Biotechnology has reported outcomes from its randomised Phase IIb ASPIRE study of intravitreal UBX1325 for diabetic ...

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

with the injection taking only a few seconds. Laser therapy involves applying small laser pulses to seal leaking blood vessels and reduce macular swelling. Laser therapy can help stabilize and ...

The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...

Protein therapies for eye disorders require frequent injections because those engineered ... way to deliver therapeutic proteins to the retina. The privately held company’s platform technology ...

In the context of retinal surgery, Bernstein would be able ... while using the surgical robot device to perform subretinal injections while also avoiding eye complications. "Robotics has taken ...

Patients with diabetic macular edema previously treated with a ranibizumab biosimilar in India experience comparable safety ...

Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide. This ...

it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of pharmacologic therapy, including intravitreal injections of anti-VEGF ...